Related Experiment Video
Updated: May 26, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Severe asthma: advances in current management and future therapy.
1National Heart and Lung Institute, Imperial College, London, United Kingdom. p.j.barnes@imperial.ac.uk
Effective treatment for severe asthma remains a challenge. New therapies targeting specific mediators, inflammation, and corticosteroid resistance offer hope for better symptom control in patients with difficult-to-treat asthma.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Pharmacology
Background:
- Severe asthma treatment is an unmet need, with many patients uncontrolled on maximal inhaled therapies.
- Poor adherence to controller medications contributes to uncontrolled symptoms.
- Emerging research explores novel therapeutic targets and delivery methods.
Purpose of the Study:
- To review current and emerging treatment strategies for severe asthma.
- To highlight new bronchodilators, anti-inflammatory agents, and approaches to corticosteroid resistance.
- To discuss the importance of identifying severe asthma subtypes and predictive biomarkers.
Main Methods:
- Review of recent clinical trials and studies on severe asthma therapeutics.
- Analysis of novel drug development targeting specific inflammatory pathways (e.g., prostaglandin D2, IL-5, IL-9, IL-13).
- Evaluation of strategies for neutrophilic inflammation and corticosteroid resistance.
Main Results:
- Long-acting anticholinergic bronchodilators show benefit in severe asthma.
- Anti-immunoglobulin E (IgE) therapy is effective in select patients.
- New targeted therapies and approaches to corticosteroid resistance are in development.
Conclusions:
- Combination inhalers and new bronchodilators may improve adherence and control.
- Targeted therapies for specific mediators and inflammation subtypes hold promise.
- Identifying biomarkers for treatment response is crucial for personalized severe asthma management.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
